These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 12719861)

  • 1. [Long term management of childhood atopic dermatitis with calcineurin inhibitors].
    Thaçi D
    Hautarzt; 2003 May; 54(5):418-23. PubMed ID: 12719861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of atopic dermatitis in adults with topical calcineurin inhibitors].
    Meurer M; Wozel G
    Hautarzt; 2003 May; 54(5):424-31. PubMed ID: 12719862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pimecrolimus: a review of its use in atopic dermatitis.
    Wellington K; Noble S
    Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.
    Nghiem P; Pearson G; Langley RG
    J Am Acad Dermatol; 2002 Feb; 46(2):228-41. PubMed ID: 11807435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M; Jenerowicz D
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimecrolimus cream for atopic dermatitis.
    Drug Ther Bull; 2003 May; 41(5):33-6. PubMed ID: 12789846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL; Yan J; Wang FS
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR; Martin JA; Finlay AY
    Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
    Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
    Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
    Fleischer AB; Boguniewicz M
    J Drugs Dermatol; 2010 May; 9(5):488-98. PubMed ID: 20480792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.
    McCollum AD; Paik A; Eichenfield LF
    Pediatr Dermatol; 2010; 27(5):425-36. PubMed ID: 20678096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis].
    Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D
    Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.